학술논문

Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma
Document Type
Article
Source
In: Biomedicine and Pharmacotherapy. (Biomedicine and Pharmacotherapy, February 2023, 158)
Subject
Language
English
ISSN
19506007
07533322